Maximilian von Zedtwitz - Böcker
Visar alla böcker från författaren Maximilian von Zedtwitz. Handla med fri frakt och snabb leverans.
6 produkter
6 produkter
Del 11 - The International Library of Critical Writings on Business and Management series
International Management of Research and Development
Inbunden, Engelska, 2008
4 666 kr
Skickas inom 7-10 vardagar
International Management of Research and Development brings together the most influential contributions to managing, organising and coordinating R&D and innovation on a global scale. In addition to papers on the fundamental principles, trends and drivers of international R&D, it covers strategies and operations of global R&D. It also provides an introduction to modern concepts such as knowledge networks, open innovation and virtual innovation. It is a key reference collection for professors and researchers wishing to understand the practical implications of industrial R&D and a valuable resource for chief technology and innovation officers keen to develop their corporate R&D more systematically.
Chemical and Pharmaceutical Industry in China
Opportunities and Threats for Foreign Companies
Inbunden, Engelska, 2005
552 kr
Skickas inom 10-15 vardagar
“Don’t miss out on China!” and “What are you doing about China?” Catch phrases like these are spreading among managers all over the world.
1 096 kr
Skickas inom 10-15 vardagar
What are the secrets of competitive R&D on a global scale? Based on research with hundreds of R&D executives from more than 80 companies and 1000 R&D laboratories, this work presents fresh concepts and trends in global R&D management. It also includes case studies from 22 best-practice companies that show how to put these concepts into practice.
Leading Pharmaceutical Innovation
Trends and Drivers for Growth in the Pharmaceutical Industry
Inbunden, Engelska, 2008
733 kr
Skickas inom 5-8 vardagar
Pharmaceutical giants have doubled their investments in drug development in the past decade only to see new drug approvals remain constant. This book investigates and highlights a set of proactive strategies aimed at generating sustainable competitive advantage based on value-generating business practices. We focus on three sources of pharmaceutical innovation: new management methods in the drug development pipeline, new technologies as enablers for cutting-edge R&D, and new forms of cooperation and internationalization, such as open innovation in the early phases of R&D. Our findings are illustrated by cases from Europe, the US, and Asia.
Chemical and Pharmaceutical Industry in China
Opportunities and Threats for Foreign Companies
Häftad, Engelska, 2010
552 kr
Skickas inom 10-15 vardagar
“Don’t miss out on China!” and “What are you doing about China?” Catch phrases like these are spreading among managers all over the world.
878 kr
Skickas inom 10-15 vardagar
If R&D and innovation in the 1990s were about more internationalization, more corporate entrepreneurship, and more information-integration, then the 2000s have been about consolidating and expanding these trends further: more globalization including the technology mavericks of China and India, more open and inbound innovation integrating external technology providers, and more web- and Intern- enabling of innovation processes by involving R&D contributors regardless of their location. The corporate R&D powerhouses of the 1980s are now mostly history. Even where they survived, they had to yield to corporate efficiency efforts and business-wide integration programs. Still, it would be unfair to belittle them in retrospect as they have found new roles in corporate R&D and innovation n- works. In fact, the very successes of centralized R&D organizations of the 1970s and 1980s made possible the revolution of globalized innovation that we have been witnessing since the 1990s. The first two editions of Managing Global Innovation, published in 1999 and 2000, were testimonials of an increasingly internationalizing world of innovation and R&D. In this third edition of Managing Global Innovation, we have retained the basic structure of two conceptual parts (I and II) and three case study parts (III, IV, V). However, we have greatly revised all chapters, including the final “Imp- cations” chapter (part VI), and incorporated new chapters and cases that illuminate and describe the recent trends in the context of the beginnings of global innovation in the 1980s and 1990s.